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 Abstract 
In order to design microarray oligonucleotides, in the context of new metabolic pathways discovery, it appears that a full 
backtranslation of oligopeptides is a promising approach. Protein to DNA reverse translation is a time-consuming task that can provide 
unreasonable quantities of data. This is why most current applications use genetic degenerated code or data mining-based techniques to 
select the best reverse translation of a short protein sequence called oligopeptide. When the purpose is only to design short oligos it is 
particularly interesting to have the complete sequences to solve the design problems of enzyme specific oligos for microarrays. In this 
paper, we revisit existing bioinformatics applications, which bring reverse translation solutions, and we present a new algorithm based 
on input oligopeptide degeneracy able to efficiently compute a full reverse translation. We propose an implementation with the C 
programming language and we show its performance statistics on simulated and real biological datasets. 
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1 Introduction 
 
Reverse translating a given peptide allows the determination of the nucleic sequences at its origin. This is a retro-
engineering process, contrary to the natural translation of RNA (Ribonucleic acid) which gives a protein sequence that 
has specific activity in the studied organisms. Applications using reverse translation - known as backtranslation - 
introduce different solutions to get the more appropriate nucleic sequence among all possibilities. The resulting sequence 
is considered as the sequence which is at the origin of the studied protein. To perform this task one uses codon that 
associates a triplet of nucleic acids to each amino acid. Each amino acid can be represented by 1, 2, 3, 4 or 6 codons. 
Furthermore, the backtranslation problem appeared after the protein synthesis mechanism discovery [9] followed-up by 
the entire genetic code decoding in 1961. Nowdays, backtranslation is required in more and more applications using 
protein to DNA or RNA passing. For instance, Molecular Phylogeny is based on genetic code to perform a phylogenetic 
tree construction with sequence homology detection. Information held by proteins is useful when constructing multiple 
DNA alignments for phylogenetic analysis [15]. In this case, backtranslation is just a substitution of amino acid by the 
existing codon in the original nucleic sequence. Thus, backtranslate a protein to DNA can preserve this information. 
Nevertheless, genomic and transcriptomic databases are used as a source of sequences for protein alignments, so it is 
possible to find CDSs (CoDing Sequences) [9] by launching a BLAST [1] program and then construct the alignment 
using ClustalW [3] program. Similar tools using backtranslation to perform an alignment are available in [2] and [14]. 
Additionally, backtranslation can be made for direct derived nucleic sequences search from a protein sequence. This 
search is based on IUB/IUPAC degenerate nucleotide base codes [13] and it assumes the use of a consensus sequence to 
represent all possible sequences corresponding to the original protein. With this approach, one protein is backtranslated to 
a unique IUB codon that represents all possibilities in only one nucleotide triplet. Software that use IUB codes to 
backtranslate a protein only uses a replacement of amino acids by corresponding IUPAC codons. Consequently, to obtain 
a nucleic sequence from an input peptide, we need to produce all the potential codons.  
Reverse translation can be also used to compute probable DNA underlying the reported amino acid substitution by 
selecting reference amino acid in regards to the codon usage preference for each organism [8]. The calculation is based on 
user-selected codon table. Several reverse translation tools are based on probability computation or statistical 
determination of amino acid codon referred to the nucleic databanks. It can use genetic algorithms [5], [6] to determine 
the most probable codon at a given position by launching a data mining algorithm on a selected databank. In addition, 
some software use neural networks data mining to similarly perform the same task [16]. Another method based on 
hierarchical clustering data mining to do backtranslation was proposed in [4]. Several methods use particularly data 
mining algorithms to find the most adapted reverse translation of a peptide. For example, Serine (S) amino acid can be 
encoded by 6 triplet nucleic codons: TCA, TCC, TCG, TCT, AGC and AGT. According to databanks, the probability to 
find a peptide with Serine amino acid which arises from a translation of nucleic sequence and having AGC codon is 26% 
when E. coli species databank is used as reference databank. So, when S amino acid is backtranslated, the tool presented 
in [13] returns the most probable codon based on species characteristics. Furthermore, similar tools use the most probable 
codon or user-selected codons to perform such a reverse translation and are detailed in [10], [17], [18] and [19]. Reverse 
translation based on distance matrix providing codon usage between given sequences, is shown in [4]. Backtranslation 
programs are often associated with complete software or packages as [8] and [13], thus belonging to a bigger application, 
which uses other elementary programs to perform bioinformatics tasks.  
Whatever the approach, the backtranslation problem presents an actual complicatedness due to the genetic code 
degeneracy. To have all possible non degenerate DNA sequences corresponding to an input peptide, to the best of our 
knowledge, no tool is available to automatically perform this task. However, working on oligopeptides with a limited 
length becomes reasonable with the current storage capacities. The problem to tackle is of exponential nature, but it is still 
tractable with an interesting size of oligopeptide which will produce less than 3 terabytes (616, knowing that we can store 
a codon on a single byte). Of course if the degeneracy is favourable we can backtranslate much longer oligopeptides.  
 In this study, we introduce a new algorithm called DegenRev that performs a high performance backtranslation of 
oligopeptides despite. The algorithm is based on a learning step which previously encodes the degeneracy for each step of 
the algorithm. 
2 DegenRev: the algorithmic model 
 
The codon table data used in DegenRev is stored in an appropriate structure that facilitates amino acid accession for each 
processed peptide. All codons are stored in an array of string. But the most important part of our algorithm is its approach 
which takes advantages of the degeneracy of each amino acid to calculate remaining oligos at a given step of peptide 
processing. First, an input peptide is stored in an array. For each amino acid i we calculate its cumulated degeneracy d( )i , 
the remaining degeneracy r( )i  and the passed degeneracy c( )i . We note NC( )i  the number of codons of the amino acid i; i 
∈ [0, pl-1]. So, the total peptide degeneracy having length pl is given by the equation (1): 
D =  ∏
i = 0
pl − 1
  NC( )i  (1) 
The cumulated degeneracy to the ith amino acid is given by the equation (2): 
d( )i  =  ∏
k = 0
i
  NC( )k  (2) 
 
The remaining degeneracy at the ith amino acid is given by the equation (3): 
r( )i  =  ∏
k = i + 1
pl
  NC( )k  (3) 
And the passed degeneracy at the ith amino acid is given by the following formula: 
 
If (i =  0) then 
c( )i  =  1 
 
Else 
 
c( )i  =  ∏
k = 1
i
  NC( )k − 1  . (4) 
While the initialization of all variables is done, the translation step begins. The program tests for each amino acid if r( )i  is 
reached. If it is the case, then the next amino acid is processed, else the current one is used. This process will be repeated 
c( )i  times as it is described in figure 1.  DegenRev performs exactly D loops using this approach without loosing time on 
reinitialising degeneracy variables. For an amino acid i, the degeneracy is given by equation (5): 
D =  d( )i  × r( )i  (5) 
The obtained oligos (nucleic sequences generated after reverse translation of the peptide) are ordered by their respective 
degeneracy. Figure 1 shows an example: 
 
Output results for the sample oligopeptide ‘KIL’ are done by the following variables: 
 
OligoPeptide: K I L 
 
i:   0 1 2 
NC(i):  2 3 6 
D:   36 
d(i):   2 6 36 
r(i):   18 6 1 
c(i):   1 2 6 
 
As shown here, our technique takes advantage of the degeneracy pre-storage to perform backtranslation task. The 
algorithm writes data in an output file containing non redundant reverse translation possibilities. Each computed oligo 
will represent a potential coding sequence part for the studied protein. The complexity of the DegenRev algorithm is 
given by the following equation: 
Complexity =  D × pl (6) 
  
Fig. 1. The oligos generated from the peptide “KIL” and ordered by the algorithm. Each amino acid’s repetition depends on passed 
degeneracy c (i) done in formula (4) which gives exactly the number of current remaining computed codon. Colours are only used to 
differentiate codons. Oligos should be taken line by line which is the order of calculation used by the algorithm. 
 
The following is a pseudo-code of the reverse translation algorithm DegenRev. The main loop, in which backtranslation is 
performed using previously described degeneracies supposed to be known for the following sub-program, is described. In 
each loop, DegenRev build current generated oligo using its own degeneracy as shown in Figure 1. The order depends on 
the initialization structure made in the beginning of the algorithm.  
Function DegenRev 
Input: 
 Peptide pep 
Output: 
 File oligos.out 
Variables: 
 Array of integers: k, l, j 
 Array of characters: oligo 
Begin  
  While m < D do 
    for i = 0 to pl do  
       Concatenate (oligo,codonl[i](pep[i])); 
       if (k[i] = r[i] - 1) then 
         k[i] := 0; 
         if (l[i] = codon_number(pep[i]) - 1) then 
           l[i] := 0; 
           if (j[i] = c[i]-1) then 
             j[i] := 0; 
            else 
             j[i]++; 
           end if 
         else 
           l[i]++; 
         end if  
       else 
         k[i]++; 
       end if 
    end for 
    write(oligo, oligos.out); 
    m := m + 1; 
    oligo := ∅; 
  end while 
End 
 
3 DegenRev Performances 
 
 
The algorithm was tested on a machine with a Xeon processor at 2.40-GHz and 2-GB RAM. As mentioned in the 
previous section, the program was developed in the C language and was compiled with the 3.4.1 version of GCC 
compiler with 64 bits system options to allow LFS (Large File Support). A first test of our algorithm was performed 
based on incremented degeneracy and minimum length i.e. for a given degeneracy of input peptide the minimum length 
was taken. For example, let be d = 373248. This degeneracy is obtained by several peptides having different lengths: 
IAARRRRR (8), KKKRRRRRR (9), KIIIIAAARR (10), and KKKKIRRRRR (11) etc... However, IAARRRRR was 
selected for this degeneracy because it is the smallest peptide that has degeneracy d. 
 
3.1   General test statistics 
 
In this section, the general behaviour of our algorithm is described, particularly when it is used to calculate all possible 
oligos for a given input peptide. Additionally, two aspects of our algorithms can be distinguished depending on the 
writing step. Indeed, first, the algorithm with the writing phase was tested in order to have the real time consumption and, 
then, it was tested without this phase in order to obtain its performance for very high degeneracies because the disk space 
limit can be reached easily when high degeneracy peptides are computed. In addition, when the algorithm is applied to 
real data, the writing step will concern only the part of oligos that have the best specificity and sensitivity characteristics 
for probe design. Execution time was given by the clock () function of C library and it returns the CPU time of our 
program. 
 
 
 Fig. 2. The global performance (t which consists of the execution time in seconds) of DegenRev algorithm using minimum length 
peptide degeneracy d. The given data concerns DegenRev with output file and without output file. The two curves have the same 
exponential look. The difference between the two curves is due to writing oligos results into an output file. 
 
In figure 2, the general performance of DegenRev algorithm shows that the algorithm is extremely efficient for short 
peptide having degeneracy about 107. In fact, to have all possible oligos for short peptides, DegenRev takes less than 1 
minute on current desktop computers. The execution time increases significantly when degeneracy is greater than 108. 
Additionally, to avoid disk quota limitation, the size of output file for each peptide should be calculated and compared to 
the available free disk space. Table 1 and figure 2 show that the execution time depends both of peptide length and its 
degeneracy.  
 
Table 1. For each tested peptide, the total degeneracy and the size of the output file increases when the degeneracy rises. 
Peptide Degeneracy Output file size (in Bytes) 
RRRRRR 46656 886464 
RRRRRRK 93312 2052864 
RRRRRRI 139968 3079296 
RRRRRRA 186624 4105728 
RRRRRRR 279936 6158592 
RRRRRRRK 559872 13996800 
RRRRRRRI 839808 20995200 
RRRRRRRA 1119744 27993600 
RRRRRRRR 1679616 41990400 
RRRRRRRRK 3359232 94058496 
RRRRRRRRI 5038848 141087744 
RRRRRRRRA 6718464 188116992 
RRRRRRRRR 10077696 282175488 
RRRRRRRRRK 20155392 624817152 
RRRRRRRRRI 30233088 937225728 
RRRRRRRRRA 40310784 1249634304 
RRRRRRRRRR 60466176 1874451456 
RRRRRRRRRRK 120932352 4111699968 
RRRRRRRRRRI 181398528 6167549952 
RRRRRRRRRRA 241864704 8223399936 
RRRRRRRRRRR 362797056 12335099904 
RRRRRRRRRRRK 725594112 26846982144 
RRRRRRRRRRRI 1088391168 40270473216 
RRRRRRRRRRRA 1451188224 53693964288 
 
In the following section we will describe the behaviour of our algorithm when oligopeptide length varies. 
 
3.2   Length influence on DegenRev performance 
 
According to figure 3, the program conserves a linear behaviour when the input peptide length increases and the 
degeneracy is keep constant.  
 
  
Fig. 3. pl is the input peptide length used in equation (1) to compute the total degeneracy which is constant in this figure. Linear like 
curves which represent DegenRev behavior when the degeneracy is fixed at 10077696 and at 60466176 and when the length is varying. 
t is the execution time in seconds. 
 
To confirm these results we tested our algorithm for a degeneracy d = 60466176 and we obtained the results described in 
figure 3. Our algorithm behaves as a linear function when the degeneracy is fixed. Moreover, The curve slope increases 
when degenerecies are greater than d as attested by the curve of degeneracy 60466176, which has a slope equal to about 5 
while the curve of degeneracy 10077696 has only a slope equal to about 1. DegenRev can compute efficiently oligos for 
peptides having a small degeneracy. The main aim is to have a degeneracy range that minimizes the whole execution time 
for a group of peptides representative of enzymatic characteristics. This program will be used as a part of more 
consequent software used to design oligonucltides for microarrays. DegenRev allows the computation of a large choice of 
oligopeptide lengths for oligos that will serve as input for enzyme specific oligos design. 
 
3.3 Degeneracy influence on DegenRev performance 
 
This section shows DegenRev behavior when input peptide length is fixed allowing us to make a decision about optimal 
length and degeneracy combination range.  
 
  
Fig. 4. pl = 18.DegenRev behavior when the length is fixed and degeneracy is varying. t is the execution time in seconds and d is the 
degeneracy. 
Obviously and as expected, the input peptide degeneracy is the most influent factor on the execution time. In fact, the 
variation of degeneracy with a fixed length shows a more important increase of the execution time than the variation of 
the oligopeptides length with a fixed degeneracy. 
 
3.4 DegenRev tested on real datasets 
 
In a bioremediation context, we tested the algorithm on data collected from the bacteria Pseudomonas sp LZT5 which has 
a gene that encodes naphthalene dioxygenase. We took the coding sequence (CDS), which represents the enzyme 
involved on those degrading capabilities, and that are referred in the UniProt/TrEMBL databank by the accession number 
“Q3LTH2”. Then, we extract all peptides having a length of 11 amino acids. This size limit corresponds to 33 mers oligos 
which is an interesting size for the design of short oligonucleotides [12]. Therefore, we obtained 175 oligopeptides ready 
to be tested by our algorithm to show all oligos derived from this enzyme. The test consists of creating a file containing 
all those oligopeptides; one peptide per line. Then full backtranslation is computed for each oligopeptide. Execution time 
for all the data is finally collected. DegenRev without file output was tested because we plan to apply our oligo design 
program [11] at run time for each found oligo. The results in figure 5 show that the whole execution time is of 101 
seconds. This is relatively short for 175 oligopeptides of 11 amino acids compared to the simulated data of table 1. The 
chosen length represents a significant scale for probe design because it generates oligos having a length of 33, which is 
the top limit for short oligos. According to such results, we see that our algorithm shows a real capability of computing 
full backtranslation on real datasets with a very reasonable execution time. Moreover, according to the results shown in 
figure 3, we know that a wide range of oligopeptides length is able to be used by our efficient full backtranslation 
program. 
 
  
Fig. 5. Cumulated execution time of the DegenRev algorithm with real data extracted from Pseudomonas sp LZT5 data. Each 
graduation corresponds to an oligopeptide of the 175 found. Visible degeneracies are automatically and randomly selected ones among 
full data. d is the degeneracy and t is the execution time. 
 
4 Conclusion and discussions 
 
We presented in this paper a new algorithm, DegenRev and an approach using full backtranslation of oligopeptides for the 
design of microarray oligonucleotides. Existing algorithms provide solution with IUB degenerated code. The algorithm 
introduced is efficient on simulated and real data, and it is the only one to give all the possible oligos coding for a given 
oligopeptide. DegenRev is very appropriate for peptide having degeneracy smaller than 109 independently from the 
peptide length, which influences on execution time very slowly. The main limitation of our algorithm is the disk space 
issue, since a few terabytes can be needed for large real datasets. However, the new hard disks for personal computers in 
manufacturers research laboratories are above 5 terabytes, they will soon be available on our desktops. In addition, in the 
near future, we will study the parallelization of this algorithm on computing clusters and grids. 
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